These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 23522341

  • 21. Primary prevention of cardiovascular diseases among hypercholesterolemic Japanese with a low dose of pravastatin.
    Nakamura H, MEGA Study Group.
    Atheroscler Suppl; 2007 Aug; 8(2):13-7. PubMed ID: 17586102
    [Abstract] [Full Text] [Related]

  • 22. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
    Pearson TA, Denke MA, McBride PE, Battisti WP, Brady WE, Palmisano J.
    Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment.
    Lahoz C, Peña R, Mostaza JM, Laguna F, García-Iglesias MF, Taboada M, Pintó X.
    Metabolism; 2005 Jun; 54(6):741-7. PubMed ID: 15931608
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J, Hoffman R, Hanson M, Veltri E.
    Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Achieving lipid goals in real life: the Dutch DISCOVERY study.
    Bots AF, Kastelein JJ, Discovery Netherlands Investigators.
    Int J Clin Pract; 2005 Dec; 59(12):1387-94. PubMed ID: 16351669
    [Abstract] [Full Text] [Related]

  • 33. Combination of low-dose niacin and pravastatin improves the lipid profile in diabetic patients without compromising glycemic control.
    Gardner SF, Marx MA, White LM, Granberry MC, Skelton DR, Fonseca VA.
    Ann Pharmacother; 1997 Jun; 31(6):677-82. PubMed ID: 9184704
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 38. Marked decrease in serum HDL cholesterol levels by combined probucol-pravastatin treatment in hypercholesterolemic NIDDM patients.
    Ikeda T.
    Diabetes Care; 1993 May; 16(5):849-50. PubMed ID: 8495635
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.